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Legionella pneumophila utilizes a type IV secretion system (T4SS) encoded by 26 dot/icm genes to replicate
inside host cells and cause disease. In contrast to all other L. pneumophila dot/icm genes, dotU and icmF have
homologs in a wide variety of gram-negative bacteria, none of which possess a T4SS. Instead, dotU and icmF
orthologs are linked to a locus encoding a conserved cluster of proteins designated IcmF-associated homolo-
gous proteins, which has been proposed to constitute a novel cell surface structure. We show here that dotU is
partially required for L. pneumophila intracellular growth, similar to the known requirement for icmF. In
addition, we show that dotU and icmF are necessary for optimal plasmid transfer and sodium sensitivity, two
additional phenotypes associated with a functional Dot/Icm complex. We found that these effects are due to the
destabilization of the T4SS at the transition into the stationary phase, the point at which L. pneumophila
becomes virulent. Specifically, three Dot proteins (DotH, DotG, and DotF) exhibit decreased stability in a
dotU icmF strain. Furthermore, overexpression of just one of these proteins, DotH, is sufficient to suppress
the intracellular growth defect of the dotU icmF mutant. This suggests a model where the DotU and IcmF
proteins serve to prevent DotH degradation and therefore function to stabilize the L. pneumophila T4SS. Due
to their wide distribution among bacterial species and their genetic linkage to known or predicted cell surface
structures, we propose that this function in complex stabilization may be broadly conserved.
Legionella pneumophila is a gram-negative bacterium that is
the causative agent of a form of pneumonia known as Legion-
naires’ disease (16). In the environment, this pathogen is an
intracellular parasite of freshwater amoebae (39). When in
contact with humans, it can cause disease by replicating inside
alveolar macrophages (20). L. pneumophila is able to survive
and replicate inside these normally bactericidal phagocytic
cells by altering their endocytic pathway to create a novel
niche, the replicative phagosome, where it can grow (19, 36).
Later during infection, the replicative phagosome can fuse with
the lysosome prior to lysis of the host cell and release of
bacteria (35).
L. pneumophila alteration of the endocytic pathway is cen-
tral to its ability to cause disease and is mediated by a large
number of genes called dot (defect in organelle trafficking) or
icm (intracellular multiplication) that encode a type IV secre-
tion system (T4SS) (29, 37). This family of secretion systems
comprises both classical plasmid transfer systems and adapted
conjugation systems used by a wide range of bacterial patho-
gens. Most T4SS have significant homology to the components
of the Agrobacterium tumefaciens VirB complex, which exports
a number of virulence factors into plant cells (6, 10). By com-
parison, homologs of the L. pneumophila dot/icm genes are
only found in a single other pathogenic T4SS, that of Coxiella
burnetii, and on the IncI plasmids ColIb-P9 and R64 (23, 32,
34).
In contrast to the other dot/icm genes, the icmF gene has at
least 27 homologs present in the finished and unfinished mi-
crobial genome database (9). Organisms that contain icmF
homologs represent diverse phylogeny, most notably the al-
pha-, beta-, and gammaproteobacteriaceae. They include plant
pathogens such as A. tumefaciens, Rhizobium leguminosarum,
and Xanthomonas axonopodis as well as the animal pathogens
Yersinia pestis, Escherichia coli O157:H7, Vibrio cholerae,
Pseudomonas aeruginosa, and Salmonella enterica (9). The only
icmF homolog characterized to date is the V. cholerae gene
VCA0120, which was initially described as a gene induced
during V. cholerae replication in rabbit ileal loops (8). Inacti-
vation of VCA0120 had pleiotropic effects including reduced
motility, increased adherence to human intestinal epithelial
cells, and enhanced conjugation as a recipient. It was specu-
lated that these phenotypes may be the result of a change in a
hypothetical cell surface structure (7, 9).
The L. pneumophila icmF gene was originally identified in a
screen for Tn903dlllacZ insertion mutants defective in the abil-
ity to kill HL-60-derived macrophages (27, 28). In contrast to
most of the other dot/icm genes, icmF is only partially required
for L. pneumophila replication in human macrophages, though
it is fully required for replication inside the more restrictive
host Acanthamoeba castellanii (27, 31). Finally, a strain lacking
icmF functions slightly better as a conjugal recipient of an
RSF1010 plasmid when compared to a wild-type L. pneumo-
phila strain similar to what occurs with the V. cholerae icmF
mutant (7, 30). The L. pneumophila icmF gene is located at one
end of dot/icm region II (27, 37) and can be found downstream
of a gene previously designated dotU (34). In this paper, we
characterize the role of icmF and dotU in the intracellular
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replication of L. pneumophila and report that they are essential
for the stability of the Dot/Icm complex.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. Bacterial strains are listed in Table 1.
The wild-type L. pneumophila strain Lp02 (thyA hsdR rpsL) is a derivative of the
serogroup 1 clinical isolate Philadelphia-1 (1). All L. pneumophila strains were
cultured with N-(2-acetamido)-2-aminoethanesulfonic acid (ACES) buffered
yeast extract as described previously (12, 17). Lp02 and Lp02 derivatives were
cultured on media supplemented with 100 g of thymidine/ml as needed. E. coli
strains XL1-Blue and DH5::pir were used for cloning. Strain XL1-Blue was
used for expression of His-tagged fusion proteins.
Strain and plasmid construction. The suicide plasmids pJB1149, pJB1720,
pJB1156, and pJB1168, used to create the dotU strains JV1116 and JV4015, the
icmF strain JV1179, and the dotU icmF strain JV1181, were constructed as
follows. Five hundred-base pair regions flanking the relevant open reading
frames or internal to the dotU gene were PCR amplified from Lp02 chromo-
somal DNA with primers engineered to have SalI, BamHI, or EagI restriction
sites. The resulting products were cut with SalI/BamHI or BamHI/EagI, cloned
in a three-piece ligation into the SalI/NotI sites of the suicide vector pSR47S
(25), and confirmed by sequencing. Next, each plasmid was transformed into the
wild-type L. pneumophila strain Lp02 where it integrated into the chromosome
via homologous recombination to generate a merodiploid strain. Merodiploids
were resolved by using a counterselection based on sucrose sensitivity, and
resulting colonies were screened for the absence of the relevant gene via PCR,
thus generating strains JV1116, JV4015, JV1179, and JV1181. Two different
dotU strains (JV1116 and JV4015) were constructed because dotU in strain
JV1116 appeared to have a slight polar effect on IcmF expression. Though
JV1116 can be fully complemented for intracellular growth by dotU, indicating
that levels of IcmF in this strain are sufficient, we chose to use a second dotU
strain (JV4015) for IcmF localization experiments, since it had no polar effect on
IcmF expression.
The cloning vector pJB908 (33) was used to create dotU, icmF, dotU icmF,
dotH, dotG, dotF, and dotHGF complementing clones. To construct plasmids
pJB1180 and pJB1186, the dotU or icmF open reading frames were PCR ampli-
fied from Lp02 chromosomal DNA with primers containing KpnI/BamHI or
XbaI/SalI restriction sites, cloned into the KpnI/BamHI or XbaI/SalI sites of
pJB908, and confirmed by sequencing. The dotU icmF double complementing
clone pJB1191 was constructed by inserting the pJB1186 XbaI/SalI (icmF) frag-
ment into the XbaI/SalI sites of pJB1180, thus placing the icmF open reading
frame downstream of dotU. The dotH, dotG, and dotF genes were each PCR
amplified from Lp02 chromosomal DNA with primers containing KpnI/BamHI,
BamHI/XbaI, or XbaI/SalI restriction sites, respectively. Products were cloned
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant properties Reference or source
E. coli
DH5::pir DH5(pir) tet::Mu 22
ER1821 E. coli F glnV44 e14-(McrA-) endA1 thi-1 (mcrC-mrr)114::IS10 New England Biolabs (Beverly, Mass.)
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F proAB
lacIqZM15 Tn10 (Tetr)
Stratagene (La Jolla, Calif.)
L. pneumophila
Lp02 L. pneumophila Philadelphia-1 Smr rpsL hsdR thyA 1
Lp03 Lp02 dotA mutant 1
JV1116 Lp02 dotU This study
JV4015 Lp02 dotU (internal) This study
JV1184 JV1116  pJB908 This study
JV1183 JV1116  pJB1180 This study
JV1188 JV1116  pJB1186 This study
JV1179 Lp02 icmF This study
JV1192 JV1179  pJB908 This study
JV1194 JV1179  pJB1186 This study
JV1181 Lp02 dotU icmF This study
JV1196 JV1181  pJB908 This study
JV1199 JV1181  pJB1191 This study
JV2572 JV1181  pJB1555 This study
JV2573 JV1181  pJB1554 This study
JV2574 JV1181  pJB2121 This study
JV2575 JV1181  pJB2132 This study
Plasmids
pKB5 RSF1010 cloning vector thyA, bla, mob 1
pJB908 pKB5 oriT 33
pJB1180 pJB908, dotU This study
pJB1186 pJB908, icmF This study
pJB1191 pJB908, dotU icmF This study
pJB1555 pJB908, dotH This study
pJB1554 pJB908, dotG This study
pJB2121 pJB908, dotF This study
pJB2132 pJB908, dotH dotG dotF This study
pSR47S R6K suicide vector (Kanr, sacB) 25
pJB1149 pSR47S with dotU flanking regions This study
pJB1720 pSR47S with dotU internal regions This study
pJB1156 pSR47S with icmF flanking regions This study
pJB1168 pSR47S with dotU icmF flanking regions This study
pQE30 Expression vector for His-tagged proteins Qiagen
pJB1537 pQE30 with dotU This study
pJB1544 pQE30 with icmF This study
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into pJB908, confirmed by sequencing, and named pJB1555, pJB1554, and
pJB2121. The dotH dotG dotF triple complementing clone pJB2132 was con-
structed by first cloning the XbaI/SalI (dotF) fragment from pJB2121 into
pJB1555 and then adding the pJB1554 BamHI/XbaI (dotG) fragment, so that the
final construct contained the dotH, dotG, and dotF open reading frames in that
order.
For DotU and IcmF protein purification and generation of antibodies, the
dotU and icmF open reading frames were PCR amplified with primers containing
BamHI or BamHI/SalI restriction sites, cloned on a BamHI (dotU) or a BamHI/
SalI (icmF) fragment into the His6 expression vector pQE30 (Qiagen, Valencia,
Calif.), and confirmed by sequencing. The plasmids were named pJB1537 (His-
DotU) and pJB1544 (His-IcmF).
Cell fractionation. One hundred optical density at 600 nm (OD600) units of
bacterial cells were grown to mid-exponential phase, harvested, and stored at
20°C until needed. For preparation of membrane fractions, cells were resus-
pended in 2.5 ml of cold 20 mM Tris (pH 8.0), 5 mM EDTA. Lysozyme was
added to 100 g/ml, and cells were incubated on ice for 1 h and then lysed by
sonication on ice (applied in 30-s bursts for a total of 4 min). The lysate was
cleared by 10 min of centrifugation at 10,000  g at 4°C, and a sample (repre-
senting the total protein fraction) was taken. The lysate was then subjected to
ultracentrifugation for 1 h at 100,000 g at 4°C to pellet the membrane fractions.
The supernatant (soluble protein fraction) was removed and transferred to a new
tube while the membrane pellet (total membrane fraction) was washed in cold 20
mM Tris (pH 8.0). Both fractions were centrifuged for 30 min at 100,000  g at
4°C, the membrane pellet was resuspended in the original volume, and samples
were taken (33).
Intracellular growth assays. The human monocytic cell line U937 was pas-
saged, and cells were differentiated as described previously (26). Mouse bone
marrow macrophages (BMM) were prepared from female A/J mice as described
previously (5). In growth assays not requiring isopropyl-	-D-thiogalactopyrano-
side (IPTG) induction of gene expression, approximately 109 L. pneumophila
cells were harvested from a 2-day 37°C patch, resuspended in sterile deionized
water, and diluted 1:4,000 (for U937 cells) or 1:1,000 (for BMM) in RPMI 1640
(BioWhittaker, Walkersville, Md.) tissue culture media prior to infection. In
growth assays where IPTG induction was used, L. pneumophila cells were grown
in broth to exponential phase, back diluted into media containing 100 M IPTG
for overexpression of dotH, dotG, or dotF, and grown to early stationary phase.
Approximately 109 bacteria were pelleted, washed one time in sterile deionized
water, resuspended in 1 ml of sterile deionized water, and then diluted 1:4,000
into RPMI. In all cases, 0.5 ml of an L. pneumophila cell suspension was added
to a monolayer of differentiated U937 cells (1  106 per well) or mouse BMM
(5  105 per well) in 24-well dishes and the mixture was coincubated for 1 h at
37°C in 5% CO2. Medium containing extracellular bacteria was then aspirated,
and cell monolayers were washed two times with 0.5 ml of RPMI (containing 100
M IPTG, where needed). Cell monolayers were maintained at 37°C in 5% CO2
for 3 days, and each day, bacteria were recovered and plated to determine the
total number of CFU in a given well. Because L. pneumophila cannot replicate
in RPMI, daily quantitation of CFU allows an accurate representation of bac-
terial intracellular growth over time.
Antibody generation and affinity purification. His-DotU and His-IcmF were
expressed by using plasmids pJB1537 and pJB1544, purified on nickel-nitrilotri-
acetic acid-agarose (Qiagen), and injected into rabbits (Cocalico, Inc., Reams-
town, Pa.) for generation of polyclonal antibodies. DotL antibodies were gener-
ated similarly (J. P. Vogel et al., unpublished data). DotB antibodies were raised
as described previously; DotB, DotU, and IcmF antibodies were affinity purified
as described previously (33). DotF, DotG, DotH, DotI, DotN, and DotO anti-
bodies were provided by Ralph Isberg. Isocitrate dehydrogenase (ICDH) anti-
bodies were provided by Linc Sonenshein.
Conjugation and sodium sensitivity assays. Conjugation assays were per-
formed as described previously (37). Briefly, 
1  109 L. pneumophila donor
cells containing plasmid pKB5 were grown to stationary phase, mixed with 
1 
1010 E. coli recipient cells (strain ER1821), and applied to a 45-mm-pore-size
hemagglutinin filter (Millipore, Bedford, Mass.) on a prewarmed agar plate.
After a 2-h incubation at 37°C, cells were resuspended in sterile deionized water
and plated on selective media to quantitate the total number of donors and
recipients in the reaction mixture. Sodium sensitivity was determined by plating
dilutions of stationary-phase L. pneumophila cells on charcoal yeast extract
thymidine plates with or without 0.65% mM NaCl, as previously described (4,
38).
RESULTS
dotU and icmF are conserved among diverse species. L.
pneumophila DotU (GenBank accession no. AAQ10306) and
IcmF (GenBank accession no. T18341) have orthologs in a
wide range of gram-negative bacterial species, with more than
27 orthologs for each protein now reported in GenBank. No-
tably, in every organism where an icmF ortholog is found, a
dotU ortholog also exists. The IcmF orthologs share 19 to 24%
identity over their entire length and are typically of a size
similar to that of L. pneumophila IcmF (973 amino acids)
(Table 2). The same is true for the corresponding DotU or-
thologs, which are close in size to that of L. pneumophila DotU
(261 amino acids). In some cases, however, DotU orthologs are
slightly larger; an example is the R. leguminosarum ImpK pro-
tein, which contains an amino-terminal domain homologous to
DotU and a carboxy-terminal domain homologous to OmpA.
In addition, some species contain multiple copies of DotU and
IcmF (Table 2) (15).
The L. pneumophila dotU and icmF genes are located at one
end of dot/icm region II, which encodes structural components
of the T4SS (29, 37) (Fig. 1). In contrast, the dotU and icmF
homologs in other organisms can be found in a conserved
TABLE 2. L. pneumophila DotU and IcmF homologs exist in a wide range of other bacteria
Homolog











1 V. cholerae VCA120 1,181 2e35 (19) VCA115 257 1e09 (23)
2 E. coli O157:H7 VT2 Sakai Z0250 1,144 7e32 (19) Z0255 253 2e07 (23)
3 Rhizobium ImpL 1,158 1e28 (21) ImpK 510 5e05 (24)
4 Salmonella serovar
Typhimurium LT2
STM0285 (SciS) 1,289 6e15 (20) SciP 434 6e05 (24)
5 A. tumefaciens AGR_L_1062 1,159 3e31 (19) AGR_L_1060 506 6e05 (23)
6 P. aeruginosa PA0077 1,101 4e40 (20) PA0078 449 3e11 (29)
7 P. aeruginosa PA1669 1,175 3e44 (19) PA1668 289 6e11 (28)
8 P. aeruginosa PA2361 1,271 ND (13)a PA2362 252 ND (17)
9 Y. pestis CO92 YPO3603 1,177 4e36 (21) YPO3598 255 3e03 (19)
10 Y. pestis YPO0515 1,150 1e22 (19) YPO0514 536 8e05 (27)
11 Y. pestis YPO2724 1,275 2e11 (18) None NAb NA
12 Y. pestis YPO1482 1,140 3e05 (22) None NA NA
13 X. axonopodis pv citri strain 306 XAC4119 1,176 3e24 (19) XAC4120 451 3e14 (30)
a ND, not detectable by BLAST search.
b NA, not applicable.
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cluster of genes that encode proteins known as IcmF-associ-
ated homologous proteins (IAHPs) (9). Three such loci have
been characterized to date, and these are found in V. cholerae,
R. leguminosarum, and S. enterica (Fig. 1) (2, 7, 15). Each locus
contains approximately a dozen proteins with various degrees
of conservation, and some IAHP clusters also contain a ClpB
homolog (15). The majority of these proteins are predicted to
localize to the membrane and likely constitute a macromolec-
ular complex of unknown function.
DotU and IcmF are partially required for intracellular
growth. To test whether dotU, like icmF, plays a role in L.
pneumophila replication, we compared the growth of the wild-
type strain Lp02 with a strain containing an in-frame deletion
of dotU (JV1116) in U937 macrophages. The wild-type strain
grew more than 1,000-fold in 3 days. In contrast, the dotU
strain was partially defective in replication, with 10- to 100-
fold-fewer CFU than strain Lp02. This is in contrast to most
dot/icm mutant strains, including the dotA null mutant strain
Lp03, which are completely defective for replication (Fig. 2A).
JV1116 (dotU) intracellular growth was restored to wild-type
levels by a dotU complementing clone and could not be re-
stored with an icmF complementing clone (Fig. 2A). This in-
dicated that the dotU mutant JV1116 can be fully comple-
mented for intracellular growth and that the intracellular
growth defect we observed was not due to polarity on the
downstream icmF gene.
To compare the L. pneumophila requirement for dotU and
icmF in U937 cells, we tested an icmF strain (JV1179) and
found that it also has a partial growth defect in this cell line.
This phenotype could be fully complemented by expression of
icmF from a plasmid (Fig. 2B). Thus, the dotU and icmF
mutants have similar intracellular growth phenotypes. In addi-
tion, a dotU icmF double deletion strain (JV1181) likewise has
a partial growth defect in U937s, indicating that the DotU and
IcmF proteins may work together to perform a common func-
tion (Fig. 2C).
The intracellular replication phenotypes of the dotU,
icmF, and dotU icmF strains were also characterized in
mouse BMM, a more stringent host (21). The growth defect
observed for the single mutants was more severe in mouse
BMM than in U937s (Fig. 3A and B). However, the mutants
were still able to replicate at low levels compared to the rep-
lication-deficient dotA null mutant Lp03. Finally, the dotU
icmF double deletion strain appeared similar to the single
mutants, confirming the observation in U937 cells (Fig. 3C).
DotU and IcmF localize to the L. pneumophila membrane.
Examination of the DotU and IcmF predicted protein se-
quences reveals few hints as to their potential functions. IcmF
is a large protein that contains a potential nucleotide binding
motif (GXXXXGKS/T) (40). In addition, it appears to possess
several transmembrane domains, consistent with localization
to the bacterial inner membrane. DotU is a smaller protein
that does not contain any obvious functional motifs and that is
also predicted to localize to the membrane. To confirm DotU
and IcmF intracellular localization, L. pneumophila extracts
were fractionated into cytoplasm and membrane samples and
subjected to Western blots with polyclonal DotU and IcmF
antibodies. Although IcmF protein was readily detected in cell
FIG. 1. IcmF and DotU orthologs are found in IAHP gene clusters. The L. pneumophila (L.p.) dotU and icmF genes (shown by red arrows)
are located adjacent to a large number of dot/icm genes (shown by blue arrows) and are immediately flanked by genes with no role in type IV
secretion (shown by white arrows). The IAHPs from V. cholerae (V.c.), R. leguminosarum (R.l.), and S. enterica (S.e.) all contain orthologs to dotU
and icmF (shown by red arrows). The IAHP clusters contain a conserved core set of proteins (shown by solid green arrows) and less well conserved
proteins that are found only in a subset of IAHP loci (indicated by stippled or checkered green arrows). Finally, most of these loci also contain
a clpB homolog (shown by a black arrow).
5986 SEXTON ET AL. INFECT. IMMUN.
 o
n
 January 29, 2014 by W







extracts from an early-stationary-phase culture, we failed to
detect any DotU (data not shown). Subsequent analysis of
whole-cell samples taken at various stages of L. pneumophila
growth revealed that DotU is present in the exponential phase
but not in the stationary phase, consistent with rapid process-
ing or degradation upon entry into stationary phase (Fig. 4).
Similarly, IcmF is also absent in the late stages of L. pneumo-
phila growth. In contrast to DotU, however, complete disap-
pearance of full-length IcmF does not appear to occur until
late in stationary phase and happens gradually (Fig. 4). This
type of growth-phase-related fluctuation in protein levels is
atypical for most Dot/Icm proteins, which appear to be consti-
tutively expressed (Vogel et al., unpublished) (Fig. 4, DotL; see
also Fig. 7, DotB).
Based on the above-described result, cell fractions generated
from exponential cells were used to determine the intracellular
localization of DotU and IcmF. As predicted, both DotU and
IcmF were found to be present almost entirely in the mem-
brane fraction (Fig. 5, lanes 1 to 3). Levels and membrane
localization of IcmF were not affected by the absence of dotU
(Fig. 5, lanes 7 to 9), confirming that this dotU strain was not
polar on the downstream icmF gene. In contrast, the loss of
icmF had a strong effect on DotU protein levels (Fig. 5, lanes
4 to 6). This result is consistent with a DotU/IcmF protein-
FIG. 2. Intracellular growth of dotU and icmF mutants in U937
monocytes. (A) The wild-type L. pneumophila strain Lp02 (squares),
the dotA mutant Lp03 (diamonds), and the dotU strain JV1116 con-
taining either the empty vector pJB908 (circles), the dotU comple-
menting clone pJB1180 (triangles), or the icmF complementing clone
pJB1186 (inverted triangles) were assayed for growth in U937 cells.
Mean numbers of CFU are plotted as a function of time. (B) The
wild-type L. pneumophila strain Lp02 (squares), the dotA mutant Lp03
(diamonds), and the icmF strain JV1179 containing either the empty
vector pJB908 (circles) or the icmF complementing clone pJB1186
(triangles) were assayed for growth in U937 cells. (C) The wild-type L.
pneumophila strain Lp02 (squares), the dotA mutant Lp03 (diamonds),
and the dotU icmF strain JV1181 containing either the empty vector
pJB908 (circles) or the dotU icmF complementing clone pJB1191 (tri-
angles) were assayed for growth in U937 cells. Assays were done in
triplicate. Error bars indicate standard deviations of the means. d, day.
FIG. 3. Intracellular growth of dotU and icmF mutants in mouse
BMM. (A) The wild-type L. pneumophila strain Lp02 (squares), the
dotA mutant Lp03 (diamonds), and the dotU strain JV1116 contain-
ing either the empty vector pJB908 (circles), the dotU complementing
clone pJB1180 (triangles), or the icmF complementing clone pJB1186
(inverted triangles) were assayed for growth in BMM. Mean numbers
of CFU are plotted as a function of time. (B) The wild-type L. pneu-
mophila strain Lp02 (squares), the dotA mutant Lp03 (diamonds), and
the icmF strain JV1179 containing either the empty vector pJB908
(circles) or the icmF complementing clone pJB1186 (triangles) were
assayed for growth in BMM. (C) The wild-type L. pneumophila strain
Lp02 (squares), the dotA mutant Lp03 (diamonds), and the dotU
icmF strain JV1181 containing either the empty vector pJB908 (cir-
cles) or the dotU icmF complementing clone pJB1191 (triangles) were
assayed for growth in BMM. Assays were done in triplicate. Error bars
indicate standard deviations of the means. d, day.
FIG. 4. DotU and IcmF disappear at different points in stationary-
phase L. pneumophila. Equivalent OD600 units of cells from L. pneu-
mophila wild-type strain Lp02 were taken at various time points during
growth in broth, from early exponential (E) through late stationary
(S) phase. Lanes 1 through 6 correspond to culture OD600s of 2.5, 2.8,
3.1, 3.2, 3.4, and 3.4, respectively. Cells became motile between OD600s
of 2.8 and 3.1, just prior to entering the stationary phase. Cell lysates
were used for DotU, IcmF, DotL, or ICDH Western blots. Solid
arrowheads point to bands that correspond to full-length proteins
while the open arrowhead indicates a smaller reactive species likely to
represent processed or partially degraded IcmF protein. The molecu-
lar masses of relevant markers (in kilodaltons) are shown on the left.
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protein interaction, as interacting proteins often stabilize each
other (13, 18).
The dotU and icmF genes are partially required for addi-
tional dot/icm-associated phenotypes. The observation that
dotU and icmF-like genes are not normally associated with
T4SS but are instead found in diverse organisms that lack T4SS
genes (Table 2) (2, 9, 15) suggests that they are not likely to be
core components of the L. pneumophila T4SS. Nevertheless,
dotU icmF mutants were incapable of wild-type intracellular
growth, a process that requires a functional Dot/Icm complex.
This phenotype was not due to a general defect in replication,
as these strains could grow normally outside of host cells in
AYET broth (data not shown). To determine whether the
intracellular growth defect of the dotU and icmF mutants was
due to an effect on the T4SS, we examined these mutant strains
for additional dot/icm-dependent phenotypes. First, the dotU,
icmF, and dotU icmF strains were tested for the ability to
transfer an RSF1010 plasmid to an E. coli recipient. While the
wild-type strain Lp02 could transfer a plasmid at a frequency of

5  106 recipients per donor cell, strains JV1116 (dotU),
JV1179 (icmF), and JV1181 (dotU icmF) did so with a
10-fold-reduced frequency. Strain Lp03 (dotA null mutant) was
incapable of transferring a plasmid above the limit of detec-
tion, 
1  109 (Fig. 6A). Thus, dotU and icmF appear to be
partially required for Dot/Icm-mediated plasmid transfer.
Next, the dotU and icmF mutants were characterized for
sodium sensitivity. Wild-type L. pneumophila is normally highly
sodium sensitive, whereas mutations in the Dot/Icm machinery
confer sodium resistance. The plating efficiencies of strains
JV1116 (dotU), JV1179 (icmF), and JV1181 (dotU icmF)
on medium with sodium were found to be 10- to 100-fold
reduced compared to the dotA null mutant strain Lp03 but
approximately 100-fold greater than the wild-type strain Lp02
(Fig. 6B), indicating a partial role for DotU and IcmF in
sodium resistance. Both the sodium sensitivity and plasmid
transfer deficiencies of strain JV1181 (dotU icmF) could be
fully complemented (data not shown). Because the dotU and
icmF mutant strains are partially defective in intracellular
growth, plasmid transfer, and sodium sensitivity, we predicted
that the DotU and IcmF proteins may directly affect the Dot/
Icm complex.
Mutations in dotU and icmF affect stability of the DotH,
DotG, and DotF proteins. To check for effects of DotU and
IcmF on the Dot/Icm complex, we performed Western blots
against Lp02 and JV1181 (dotU icmF) whole-cell extracts
with a panel of Dot/Icm antibodies. We found that the DotH,
DotG, and DotF proteins were affected for stability in the dotU
icmF mutant strain compared to wild-type strain Lp02 (Fig. 7).
Altered protein levels were only apparent in whole-cell extracts
taken from late-exponential- or stationary-phase cultures, rem-
iniscent of the DotU processing previously observed. The fact
that DotHGF destabilization correlates with DotU processing
suggests that the latter event may be required for the normal
activity of DotU.
The DotG protein was the most profoundly altered by the
absence of dotU and icmF and could only be found as an

75-kDa breakdown product in the late stages of in vitro
growth. While levels of full-length DotF were not markedly
reduced in the dotU icmF strain, an 
25-kDa breakdown
product not seen in the wild-type strain appeared in the late
stages of growth (Fig. 7). In contrast, levels of full-length DotH
protein were reduced in the late stages of JV1181 (dotU
icmF) growth compared to those of Lp02, but this did not
correlate with a visible increase in breakdown product (Fig. 7).
All observed stability effects were identical in the dotU,
icmF, and dotU icmF strains and could be complemented
(data not shown). Notably, these effects were specific to a
subset of Dot/Icm proteins, as the majority were not destabi-
lized in the dotU icmF strain; specifically, levels of DotB,
FIG. 5. Subcellular localization of DotU and IcmF. (A) Total pro-
tein (T, lanes 1, 4, and 7), total soluble protein (S, lanes 2, 5, and 8),
and total membrane protein (M, lanes 3, 6, and 9) fractions were taken
from equivalent OD600 units of three L. pneumophila strains and were
subjected to DotU and IcmF Western blots. Strains included the wild-
type Lp02 strain (lanes 1 to 3), the icmF strain JV1179 (lanes 4 to 6),
and the dotU strain JV4015 (lanes 7 to 9). The molecular masses of
relevant markers (in kilodaltons) are shown on the left. Results are
representative of those of several experiments.
FIG. 6. Conjugation and salt resistance phenotypes of dotU and
icmF mutants. (A) The following L. pneumophila strains were assayed
for the ability to transfer an RSF1010 plasmid to E. coli recipient cells:
wild-type strain Lp02 (column 1), dotA mutant strain Lp03 (column 2),
dotU strain JV1116 (column 3), icmF strain JV1179 (column 4), and
dotU icmF strain JV1181 (column 5). The conjugation frequency
was calculated as the number of E. coli recipients per L. pneumophila
donor cell. Assays were done in triplicate. Error bars indicate the
standard deviations of the means. (B) The plating efficiency on 0.65%
NaCl was determined for strains used in panel A, and is shown here as
the percentage of NaCl-resistant CFU in a cell population. The strains
were wild-type Lp02 (column 1), dotA mutant Lp03 (column 2), the
dotU strain JV1116 (column 3), the icmF strain JV1179 (column 4),
and the dotU icmF strain JV1181 (column 5). Assays were done in
triplicate. Error bars indicate standard deviations of the means.
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DotI, DotL, DotN, and DotO were not altered. Thus, DotU
and IcmF affect the stability of a subset of Dot/Icm proteins.
Overexpression of dotH suppresses the intracellular growth
defect of a dotU icmF mutant. To determine whether the dot/
icm phenotypes of the dotU icmF strain were caused only by
the reduced levels of DotH, DotG, and DotF, we expressed the
corresponding genes in strain JV1181 (dotU icmF) and as-
sayed intracellular growth. We found that simultaneous over-
expression of dotHGF was sufficient to eliminate the dotU
icmF intracellular growth defect in U937 cells (Fig. 8A).
Furthermore, overexpression of just the dotH gene alone was
able to suppress the growth defect, whereas this effect was not
seen with just the dotF or dotG complementing clones (Fig. 8B
to D).
One explanation for this is that DotU and IcmF directly
affect only DotH stability, and the decreased levels of DotG
and DotF result indirectly from lowered levels of DotH. There-
fore, we tested whether overexpression of dotH in the dotU
icmF strain could restore wild-type levels of DotG and DotF.
We compared DotH, DotG, and DotF protein levels in the
wild-type strain Lp02, the dotU icmF strain, or the dotU
icmF strain containing the dotH complementing clone
pJB1555, each exposed to a range of IPTG concentrations.
Expression of dotH with all concentrations of IPTG resulted in
overproduction of DotH (Fig. 9, compare lanes 9 to 12 with
lanes 5 to 8). Moreover, expression of dotH restored wild-type
levels of DotG and eliminated the apparent degradation of
DotF. These findings suggest the DotU and IcmF proteins
work together to stabilize the Dot/Icm complex by maintaining
proper levels of functional DotH, which is required for the
stability of DotG and DotF.
DISCUSSION
We have shown here that the dotU gene, adjacent to icmF on
the L. pneumophila chromosome, is required for the optimal
intracellular growth of this organism. Loss of either dotU
alone, icmF alone, or both genes causes a similar impairment
in intracellular replication of L. pneumophila. We have ob-
served that several of the Dot/Icm proteins, DotH, DotG, and
DotF, appear to be significantly destabilized in a dotU icmF
mutant strain. This destabilization can be suppressed by over-
production of a single gene, dotH, indicating that the DotH
protein is likely a key factor in the stability of a putative
DotHGF subcomplex. Furthermore, overexpression of dotH
was sufficient to abolish the intracellular growth defect of the
dotU icmF mutant strain, suggesting that destabilization of
DotH is the critical factor inhibiting intracellular replication in
the dotU icmF background. Since DotH, DotG, and DotF
are components of the Dot/Icm secretion machinery and since
FIG. 7. DotG, DotF, and DotH protein levels are altered in a
dotU icmF strain. Equivalent OD600 units of cells from the L.
pneumophila wild-type strain Lp02 (lanes 1 to 4) or the dotU icmF
strain JV1181 (lanes 5 to 8) were taken at the early (E), mid-exponen-
tial (M), late exponential (L), and stationary (S) phases of growth and
used as total protein samples for DotG, DotF, or DotH Western blots.
The same samples were used for a DotB Western blot as a negative
control. The molecular masses of relevant markers (in kilodaltons) are
shown on the left. Solid arrowheads point to bands that correspond to
full-length proteins while open arrowheads indicate smaller reactive
species likely to represent processed or partially degraded proteins.
Results are representative of those of several experiments.
FIG. 8. Suppression of dotU icmF intracellular growth defect by
overexpression of DotH. (A) The wild-type L. pneumophila strain
Lp02 (squares), the dotA mutant Lp03 (diamonds), and the dotU
icmF strain JV1181 containing either the empty vector pJB908 (cir-
cles), the dotU icmF complementing clone pJB1191 (triangles), or the
dotHGF complementing clone pJB2132 (hatched squares) were as-
sayed for growth in U937 cells. Mean numbers of CFU are plotted as
a function of time. (B) The wild-type L. pneumophila strain Lp02
(squares), the dotA mutant Lp03 (diamonds), and the dotU icmF
strain JV1181 containing either the empty vector pJB908 (circles), the
dotU icmF complementing clone pJB1191 (triangles), or the dotH
complementing clone pJB1555 (hatched squares) were assayed for
growth in U937 cells. (C) The wild-type L. pneumophila strain Lp02
(squares), the dotA mutant Lp03 (diamonds), and the dotU icmF
strain JV1181 containing either the empty vector pJB908 (circles), the
dotU icmF complementing clone pJB1191 (triangles), or the dotG
complementing clone pJB1554 (hatched squares) were assayed for
growth in U937 cells. (D) The wild-type L. pneumophila strain Lp02
(squares), the dotA mutant Lp03 (diamonds), and the dotU icmF
strain JV1181 containing either the empty vector pJB908 (circles), the
dotU icmF complementing clone pJB1191 (triangles), or the dotF com-
plementing clone pJB2121 (hatched squares) were assayed for growth
in U937 cells. Growth curves were determined in the presence of 100
M IPTG. Assays were done in triplicate. Error bars indicate standard
deviations of the means. d, day.
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this machinery is known to be of critical importance for alter-
ation of the endocytic pathway, it is reasonable to conclude
that the dotU icmF intracellular growth defect likely results
from mistargeting of L. pneumophila cells early in infection.
The icmF gene was originally identified in a screen for L.
pneumophila mutants defective in the ability to kill HL-60-
derived macrophages (27, 28). dotU, immediately upstream of
icmF, was first identified via a transposon insertion that im-
paired the ability of L. pneumophila to cause disease in a
guinea pig model of infection (11). However, since the inser-
tion was not complemented, it remained possible that the phe-
notype was simply due to a polar effect on the downstream
icmF gene (11). In this report, we have generated a nonpolar
dotU strain that displays a partial intracellular growth defect
similar to an icmF strain. The dotU icmF double mutant
has a phenotype identical to that of either single mutant, which
suggests that the two proteins may function together. This
notion is supported by several facts. First, the two genes appear
to be carried on a single operon, a trait often indicative of
genes that perform a similar activity. Second, the proteins
colocalize to the L. pneumophila membrane. Finally, loss of the
IcmF protein affects the stability of DotU, a trait common
among proteins that interact (13, 18).
It was a formal possibility that the intracellular growth defect
seen in dotU icmF mutants was independent of the T4SS.
However, several lines of evidence exist to the contrary. First,
the dotU icmF mutant is partially resistant to low levels of
sodium added to the media, a trait shared with other dot/icm
mutants. Second, the dotU icmF mutant is partially defec-
tive for transfer of a plasmid, a second trait shared with the
other dot/icm mutants. Finally, the dotU icmF mutant is able
to suppress the lethality caused by the loss of the dotL gene
(Vogel et al., unpublished). In certain strains of L. pneumo-
phila, loss of the DotL protein has been observed to be a lethal
event that can be suppressed by inactivation of the majority of
the dot/icm genes. Thus, suppression of dotL lethality is an
additional dot/icm phenotype (Vogel et al., unpublished).
Taken together, these data suggest that while DotU and IcmF
are not likely to be core components of the Dot/Icm complex,
they somehow modify it.
Consistent with this, we observed degradation of at least
three Dot/Icm proteins in the dotU icmF strain background:
DotF, DotG, and DotH. Although DotH is predicted to local-
ize to the inner membrane by sequence analysis, it has been
shown to be extruded on the L. pneumophila cell surface dur-
ing infection (41). DotF has been shown to interact with sev-
eral Dot/Icm secreted substrates by a two-hybrid system (24).
DotG has limited similarity to the A. tumefaciens VirB10 pro-
tein, a core component of the VirB T4SS, in which it forms a
subcomplex with VirB9 and VirB11 (14). Based on the homol-
ogy of DotG to VirB10 and the data presented here, it is
possible that DotF, DotG, and DotH form a similar subcom-
plex in L. pneumophila.
Overexpression of dotH alone was sufficient to suppress the
destabilization of the Dot/Icm complex due to loss of dotU and
icmF, resulting in restored levels of DotG and DotF and elim-
ination of the dotU icmF intracellular growth defect. This
suggests that DotH may be the key component of a proposed
DotHGF subcomplex. Analysis of dotH, dotG, and dotF
strains is in keeping with this. Levels of DotH protein are
unaffected by mutations in dotG or dotF while levels of DotF
are mildly affected by mutations in dotH but not dotG, and
finally, levels of DotG are drastically affected by mutations in
either dotH or dotF (Vogel et al., unpublished). Therefore,
DotU and IcmF may act directly on DotH, the disruption of
which would then affect the DotG and DotF proteins.
The loss of dotU/icmF results in degradation of components
of the Dot/Icm complex at the transition from exponential
phase into stationary phase. Based on this growth phase spec-
ificity, it is apparent that dotU and icmF are critical to L.
pneumophila precisely at the time when it becomes virulent (3).
Curiously, DotU itself also appears to be processed and/or
degraded at the transition into the virulent state, suggesting
that this event may be important in DotU and/or IcmF func-
tion.
Data shown here are consistent with a role for L. pneumo-
phila DotU and IcmF as accessory factors to the type IV
secretion machinery, protecting it from degradation (Fig. 10).
One possibility is that they assist in the assembly of a functional
Dot/Icm complex and that in their absence the complex mis-
FIG. 9. Suppression of dotU icmF protein aberrations by over-
expression of DotH. L. pneumophila wild-type strain Lp02 (lanes 1 to
4) or dotU icmF strain JV1181 containing either the empty vector
pJB908 (lanes 5 to 8) or the dotH complementing clone pJB1555 (lanes
8 to 12) was grown in the presence of 0, 10, 100, or 1,000 M IPTG to
stationary phase. Whole-cell samples (equivalent OD600 units) were
taken and subjected to DotH, DotG, or DotF Western blots. The
molecular masses of relevant markers (in kilodaltons) are shown on
the left. Arrowheads are as described in the legend to Fig. 7.
FIG. 10. Model of how DotU and IcmF prevent destabilization of
the Dot/Icm complex. The DotU and IcmF proteins localize to the
inner membrane where they likely work together to shield one or more
components of the Dot/Icm complex from degradation by an as yet
unidentified protease. In the absence of DotU/IcmF, the subcomplex
DotH, DotG, and DotF is selectively targeted for proteolysis.
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assembles, leading to partial proteolysis. Alternatively, DotU
and IcmF could be critical components for maintaining the
assembled complex in a stable and active form, thus protecting
it from destabilization and proteolysis in the stationary phase.
A third possibility is that these proteins function to regulate
the Dot/Icm complex, controlling a switch from an inactive to
an active T4SS in response to growth phase; DotU degradation
and processing could be the key event in this process. Finally,
these proteins could be involved in recycling of the L. pneu-
mophila T4SS.
One of the most intriguing features of DotU and IcmF is
their high degree of conservation among diverse bacterial spe-
cies. In many organisms, dotU and icmF orthologs are found in
IAHP loci, which have been proposed to encode cell surface
structures (2, 9, 15). Inactivation of the icmF homolog in the V.
cholerae IAHP locus appeared to have pleiotropic effects on
cell surface structures (7, 9). Deletion of the S. enterica IAHP
locus resulted in a slightly decreased ability to invade eukary-
otic cells (15). Although the precise function of these IAHP
loci remains unknown, they appear to encode a cell surface
organelle. In fact, the R. leguminosarum IAHP locus (desig-
nated imp), involved in nodule formation, has been shown to
encode a temperature-dependent secretion system (2). Thus,
similar to the case with L. pneumophila, the dotU and icmF
orthologs are genetically linked to macromolecular membrane-
spanning complexes. Whether for T4SS or IAHP clusters,
DotU and IcmF proteins are likely to serve a related function
as novel accessory factors that maintain the stability of mem-
brane complexes.
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